Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da Mama
Autor(a) principal: | |
---|---|
Data de Publicação: | 2023 |
Outros Autores: | , |
Tipo de documento: | Artigo |
Idioma: | por |
Título da fonte: | Revista Brasileira de Cancerologia (Online) |
DOI: | 10.32635/2176-9745.RBC.1985v31n4.3358 |
Texto Completo: | https://rbc.inca.gov.br/index.php/revista/article/view/3358 |
Resumo: | From January of 1973 to December of 1983, 59 patients with breast cancer, treated conservatively by surgery, were refered to radiotherapy at the Instituto Nacional de Câncer. The mean age was 53 years (range: 24-83 years) and 50% of the patients were pre-menopausal. The clinical staging revealed 13 patients with T1 tumors, 34 with T2 tumors and three with T3 tumors. In nine patients this information was not available. The axilla was clinically involved in 10 cases and was surgically staged in 29 patients with a mean number of 14,2 lymphnodes removed (range: 2-36). The clinical/surgical correlation was 63%. Following tumorectomy (56% of the cases), quadrantectomy (39%) or biopsy only (3%), patients received radiotherapy to the breast with 5000 cGy being delivered. A boost dose of 1000-2000 cGy to the tumor bed followed the primary treatment. All patients were treated with cobalt therapy and electrons (boost dose). The lymphatics were irradiated in 48% of the cases. The overall survival rate at 5 years was 78% with 65% of the patients surviving free of disease (locally and distantly) at the same period. Four patients (7%) failed in the breast, three (5%) in the axiliar lymphnodes and nine (15%) distantly. The cosmetic results were considered excellent and good in 60% of the cases and this was most frequently observed in those patients treated by tumorectomy. The conservative treatment of breast cancer seems to be an acceptable option to this pathology. It offers to the patient an extremely satisfactory cosmetic result while keeping surviva! and local control similar to most mutilating treatments. |
id |
INCA-1_5923853e8d8fe3e1ed0e2c79dfd28ae3 |
---|---|
oai_identifier_str |
oai:rbc.inca.gov.br:article/3358 |
network_acronym_str |
INCA-1 |
network_name_str |
Revista Brasileira de Cancerologia (Online) |
spelling |
Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da MamaCâncer da MamaTratamento ConservadorRadioterapiaBreast CancerConservative TreatmentRadiotherapyFrom January of 1973 to December of 1983, 59 patients with breast cancer, treated conservatively by surgery, were refered to radiotherapy at the Instituto Nacional de Câncer. The mean age was 53 years (range: 24-83 years) and 50% of the patients were pre-menopausal. The clinical staging revealed 13 patients with T1 tumors, 34 with T2 tumors and three with T3 tumors. In nine patients this information was not available. The axilla was clinically involved in 10 cases and was surgically staged in 29 patients with a mean number of 14,2 lymphnodes removed (range: 2-36). The clinical/surgical correlation was 63%. Following tumorectomy (56% of the cases), quadrantectomy (39%) or biopsy only (3%), patients received radiotherapy to the breast with 5000 cGy being delivered. A boost dose of 1000-2000 cGy to the tumor bed followed the primary treatment. All patients were treated with cobalt therapy and electrons (boost dose). The lymphatics were irradiated in 48% of the cases. The overall survival rate at 5 years was 78% with 65% of the patients surviving free of disease (locally and distantly) at the same period. Four patients (7%) failed in the breast, three (5%) in the axiliar lymphnodes and nine (15%) distantly. The cosmetic results were considered excellent and good in 60% of the cases and this was most frequently observed in those patients treated by tumorectomy. The conservative treatment of breast cancer seems to be an acceptable option to this pathology. It offers to the patient an extremely satisfactory cosmetic result while keeping surviva! and local control similar to most mutilating treatments.No período de janeiro de 1973 a dezembro de 1983, 59 pacientes com carcinoma da mama, tratadas conservadoramente, foram encaminhadas ao serviço de radioterapia do Instituto Nacional de Câncer. A idade média do grupo foi de 53 anos (variação: 24 a 83 anos), com 50% das pacientes em pré-menopausa. O estadiamento clínico revelou 13 pacientes com tumores TI, 34 com tumores T2 e três com tumores T3. Em nove pacientes essa informação não pôde ser obtida. A axila estava clinicamente positiva em 10 casos e foi cirurgicamente estadiada em 29 pacientes com um número médio de linfonodos retirados de 14,2 (variação: 2-36). A correlação clínica/cirúrgica foi de 63%. Após tumorectomia (56% das pacientes), quadrantectomia (39%). ou biópsia (3%). As pacientes eram submetidas à irradiação de todo o parênquima mamário com dose de 5000 cGy seguida de reforço sobre o leito tumoral (1000-2000 cGy). Todas as pacientes foram tratadas com cobaltoterapia e elétrons. As cadeias linfáticas foram irradiadas em 48% dos casos. A sobrevida aos 5 anos foi de 78% com 64% das pacientes sobrevivendo livre de doença (local e a distância) ao término desse período. Quatro pacientes (7%) falharam na mama, três (5%) na axila e nove (15%) a distância. O resultado cosmético foi considerado excelente e bom em 60% dos casos e isso foi observado mais frequentemente nas pacientes tratadas com tumorectomia. O tratamento conservador do câncer da mama parece ser uma opção aceitável de tratamento para essa patologia. A não mutilação do órgão não altera os resultados e oferece à paciente um resultado cosmético extremamente satisfatório.INCA2023-08-07info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionArtigos, Avaliado pelos paresapplication/pdfhttps://rbc.inca.gov.br/index.php/revista/article/view/335810.32635/2176-9745.RBC.1985v31n4.3358Revista Brasileira de Cancerologia; Vol. 31 No. 4 (1985): Dec.; 243-248Revista Brasileira de Cancerologia; Vol. 31 Núm. 4 (1985): dic.; 243-248Revista Brasileira de Cancerologia; v. 31 n. 4 (1985): dez.; 243-2482176-9745reponame:Revista Brasileira de Cancerologia (Online)instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)instacron:INCAporhttps://rbc.inca.gov.br/index.php/revista/article/view/3358/2196https://creativecommons.org/licenses/by/4.0info:eu-repo/semantics/openAccessSouhami, LuisCarvalho Filho, Jurandir P.Guizzardi, Miguel F.2023-08-07T20:41:53Zoai:rbc.inca.gov.br:article/3358Revistahttps://rbc.inca.gov.br/index.php/revistaPUBhttps://rbc.inca.gov.br/index.php/revista/oairbc@inca.gov.br0034-71162176-9745opendoar:2023-08-07T20:41:53Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA)false |
dc.title.none.fl_str_mv |
Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da Mama |
title |
Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da Mama |
spellingShingle |
Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da Mama Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da Mama Souhami, Luis Câncer da Mama Tratamento Conservador Radioterapia Breast Cancer Conservative Treatment Radiotherapy Souhami, Luis Câncer da Mama Tratamento Conservador Radioterapia Breast Cancer Conservative Treatment Radiotherapy |
title_short |
Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da Mama |
title_full |
Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da Mama |
title_fullStr |
Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da Mama Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da Mama |
title_full_unstemmed |
Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da Mama Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da Mama |
title_sort |
Cirurgia Conservadora e Radioterapia no Tratamento do Câncer da Mama |
author |
Souhami, Luis |
author_facet |
Souhami, Luis Souhami, Luis Carvalho Filho, Jurandir P. Guizzardi, Miguel F. Carvalho Filho, Jurandir P. Guizzardi, Miguel F. |
author_role |
author |
author2 |
Carvalho Filho, Jurandir P. Guizzardi, Miguel F. |
author2_role |
author author |
dc.contributor.author.fl_str_mv |
Souhami, Luis Carvalho Filho, Jurandir P. Guizzardi, Miguel F. |
dc.subject.por.fl_str_mv |
Câncer da Mama Tratamento Conservador Radioterapia Breast Cancer Conservative Treatment Radiotherapy |
topic |
Câncer da Mama Tratamento Conservador Radioterapia Breast Cancer Conservative Treatment Radiotherapy |
description |
From January of 1973 to December of 1983, 59 patients with breast cancer, treated conservatively by surgery, were refered to radiotherapy at the Instituto Nacional de Câncer. The mean age was 53 years (range: 24-83 years) and 50% of the patients were pre-menopausal. The clinical staging revealed 13 patients with T1 tumors, 34 with T2 tumors and three with T3 tumors. In nine patients this information was not available. The axilla was clinically involved in 10 cases and was surgically staged in 29 patients with a mean number of 14,2 lymphnodes removed (range: 2-36). The clinical/surgical correlation was 63%. Following tumorectomy (56% of the cases), quadrantectomy (39%) or biopsy only (3%), patients received radiotherapy to the breast with 5000 cGy being delivered. A boost dose of 1000-2000 cGy to the tumor bed followed the primary treatment. All patients were treated with cobalt therapy and electrons (boost dose). The lymphatics were irradiated in 48% of the cases. The overall survival rate at 5 years was 78% with 65% of the patients surviving free of disease (locally and distantly) at the same period. Four patients (7%) failed in the breast, three (5%) in the axiliar lymphnodes and nine (15%) distantly. The cosmetic results were considered excellent and good in 60% of the cases and this was most frequently observed in those patients treated by tumorectomy. The conservative treatment of breast cancer seems to be an acceptable option to this pathology. It offers to the patient an extremely satisfactory cosmetic result while keeping surviva! and local control similar to most mutilating treatments. |
publishDate |
2023 |
dc.date.none.fl_str_mv |
2023-08-07 |
dc.type.driver.fl_str_mv |
info:eu-repo/semantics/article info:eu-repo/semantics/publishedVersion Artigos, Avaliado pelos pares |
format |
article |
status_str |
publishedVersion |
dc.identifier.uri.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/3358 10.32635/2176-9745.RBC.1985v31n4.3358 |
url |
https://rbc.inca.gov.br/index.php/revista/article/view/3358 |
identifier_str_mv |
10.32635/2176-9745.RBC.1985v31n4.3358 |
dc.language.iso.fl_str_mv |
por |
language |
por |
dc.relation.none.fl_str_mv |
https://rbc.inca.gov.br/index.php/revista/article/view/3358/2196 |
dc.rights.driver.fl_str_mv |
https://creativecommons.org/licenses/by/4.0 info:eu-repo/semantics/openAccess |
rights_invalid_str_mv |
https://creativecommons.org/licenses/by/4.0 |
eu_rights_str_mv |
openAccess |
dc.format.none.fl_str_mv |
application/pdf |
dc.publisher.none.fl_str_mv |
INCA |
publisher.none.fl_str_mv |
INCA |
dc.source.none.fl_str_mv |
Revista Brasileira de Cancerologia; Vol. 31 No. 4 (1985): Dec.; 243-248 Revista Brasileira de Cancerologia; Vol. 31 Núm. 4 (1985): dic.; 243-248 Revista Brasileira de Cancerologia; v. 31 n. 4 (1985): dez.; 243-248 2176-9745 reponame:Revista Brasileira de Cancerologia (Online) instname:Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) instacron:INCA |
instname_str |
Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
instacron_str |
INCA |
institution |
INCA |
reponame_str |
Revista Brasileira de Cancerologia (Online) |
collection |
Revista Brasileira de Cancerologia (Online) |
repository.name.fl_str_mv |
Revista Brasileira de Cancerologia (Online) - Instituto Nacional de Câncer José Alencar Gomes da Silva (INCA) |
repository.mail.fl_str_mv |
rbc@inca.gov.br |
_version_ |
1822182076119515136 |
dc.identifier.doi.none.fl_str_mv |
10.32635/2176-9745.RBC.1985v31n4.3358 |